Key result
Interleukin 1β inhibition shows promise as an anti-inflammatory strategy for atherosclerotic coronary disease.
Answers are grounded in this paper and cite their sources.
PURPOSE OF REVIEW: Atherosclerosis is greatly influenced by inflammatory mediators at all phases. Recent studies have suggested a causal role of one such mediator, interleukin 1β (IL-1β), in the development of atherosclerotic vascular disease. This review highlights recent investigation of the role of IL-1β in atherosclerosis and the potential of its inhibition as a promising therapeutic strategy for the treatment of atherosclerotic vascular disease. RECENT FINDINGS: Studies in animals have generally shown decreased atherosclerotic plaque burden in atherosclerosis-prone mice deficient in IL-1β and increased plaque in mice exposed to excess IL-1β. In humans, IL-1β was found in greater concentrations in atherosclerotic human coronary arteries compared with normal coronary arteries. Preclinical and clinical studies of IL-1β inhibition have shown efficacy in the treatment of several inflammatory disorders, suggesting that IL-1β may be a novel therapeutic target for anti-inflammatory therapy in atherosclerosis, such as coronary artery disease (CAD). SUMMARY: IL-1β inhibition offers an interesting and biology-based opportunity to test the potential beneficial effects of an anti-inflammatory therapeutic strategy in patients with CAD. A large clinical trial evaluating the impact of IL-1β inhibition in CAD is ongoing and will be an important test of the inflammation hypothesis in CAD.
No takes yet. Share an insight, caveat, or question.
Qamar et al. (2012) conducted a review in Atherosclerotic vascular disease / Coronary artery disease (CAD). Interleukin 1β (IL-1β) inhibition was evaluated. Interleukin 1β inhibition represents a promising anti-inflammatory therapeutic strategy for atherosclerotic vascular disease and coronary artery disease, with a large clinical trial currently ongoing.
Synapse has enriched 10 related papers. Consider them for comparative context: